fig3
![Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy](https://image.oaes.cc/8a221065-081d-4216-a0e0-cc95ac1b2f02/cdr-2023-21.fig.3.jpg)
Figure 3. Correlation between Phospho-TCTP expression and response to trastuzumab therapy. Representative images of the immunohistochemical staining of phospho-TCTP in HER2 + BC patients (A) responsive and (B) non-responsive to trastuzumab. From Lucibello et al. “Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells”. Oncotarget, 2015